image
Adaptimmune Therapeutics plc ADAP
Healthcare - Biotechnology - NASDAQ - GB
Watchlist
$ 0.5866
-0.778 %
$ 150 M
Market Cap
-1.63
P/E
INCOME STATEMENT
60.3 M REVENUE
122.05%
Growth Rates
1Year 122.05%
3Years 147.88%
5Years 0.26%
7Years 22.94%
10Years 0.00%
-138 M OPERATING INCOME
15.81%
Growth Rates
1Year 15.81%
3Years -1.14%
5Years -10.88%
7Years -9.57%
10Years -30.89%
-114 M NET INCOME
31.18%
Growth Rates
1Year 31.18%
3Years 4.34%
5Years -3.58%
7Years -6.86%
10Years -28.41%
EFFICIENCY
Earnings Waterfall Adaptimmune Therapeutics plc
image
Revenue 60.3 M
Cost Of Revenue 9.86 M
Gross Profit 50.4 M
Operating Expenses 200 M
Operating Income -138 M
Other Expenses -24.2 M
Net Income -114 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Jun-2015 Jun-2014 Jun-2013
REVENUE
Revenue 60.3 27.1 6.1 4.0 1.1 59.5 37.8 14.2 10.7 0.6 0
GROSS PROFIT
Cost Of Revenue 9.9 127.7 111.1 91.6 97.5 0 0 0 0 0 0
Gross Profit 50.4 (100.6) (104.9) (87.6) (96.4) 59.5 37.8 14.2 10.7 0.6 0
OPERATING INCOME
Operating Expenses 200.0 191.1 168.4 137.4 140.9 141.9 118.5 87.0 33.8 15.0 9.4
Selling, General and Administrative Expenses 73.5 63.4 57.3 45.8 43.4 43.6 31.1 23.2 11.3 2.7 1.2
Research and Development Expenses 126.5 127.7 111.1 91.6 97.5 98.3 87.4 63.8 23.2 12.5 8.1
Operating Income (138.0) (164.0) (162.2) (133.4) (139.8) (82.4) (80.7) (72.8) (23.1) (14.4) (9.4)
PRE-TAX INCOME
Interest Income Expense 0 0 0 0 0 0.4 2.2 0 (0.5) 6.81 K 6.08 K
Total Other Income 25.5 (1.3) 4.9 3.5 2.8 (12.7) 11.0 2.1 (3.2) 2.8 5 K
Pre-Tax Income (112.5) (163.0) (157.3) (129.9) (136.9) (95.0) (69.7) (70.7) (23.7) (14.4) (9.3)
NET INCOME
Tax Provision 1.3 2.5 0.8 0.2 0.2 0.5 0.5 0.9 (2.1) (1.7) (0.9)
Net Income (113.9) (165.5) (158.1) (130.1) (137.2) (95.5) (70.1) (71.6) (21.6) (12.7) (8.5)
EPS 0.57 1.03 1.01 0.91 1.31 0.98 0.8 1.01 0.6 0.0299 0.0199